Refine by
Clinical Research Data Articles & Analysis
3 news found
xCures, Inc., a clinical study platform provider, and Oblato, Inc., a biotechnology company, are pleased to announce the availability of OKN-007 through an intermediate size expanded access program (iEAP) for eligible patients with pediatric diffuse midline glioma (DMG), inclusive of diffuse intrinsic pontine glioma (DIPG). Oblato is currently developing OKN-007 as a treatment for glioblastoma ...
ByxCures
Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base. Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi ...
Thermo Fisher Scientific will host a symposium featuring customer presentations that highlight the latest efforts in tumor mutation burden (TMB) standardization by its European consortium, and clinical research data focused on the application of this emerging biomarker to help guide selection of immunotherapies. The talks will take place Sept. 10 during the 30th European Congress of Pathology ...